ANZMTG - Australia and New Zealand Melanoma Trials Group Home | Login
ANZMTG - Australia and New Zealand Melanoma Trials Group
 

LOGIN



Please enter your username and password.


Username

Password


  
ANZMTG
 

ANZMTG 01.13 Trial - A randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary disease

There are very few psychosocial resources designed to address the information and support needs of melanoma patients. This randomised controlled clinical trials  aims to evaluate the efficacy of a psycho-educational intervention in reducing fear of melanoma recurrence (defined in this study as fear of melanoma recurrence as well as fear of developing new primary disease) in melanoma survivors at high risk of developing new primary melanoma, compared to usual care.

Study Status: Ongoing Follow Up; Closed to recruitment
ANZ Clinical Trials Registry number: ACTRN12613000304730
 
Principal Investigator's details:
Dr Anne Cust 
The University of Sydney 
Email: anne.cust@sydney.edu.au 
 
Dr Nadine Kasparian
The University of New South Wales
Email: n.kasparian@unsw.edu.au 

ANZMTG coordinator details:
The Poche Centre, 40 Rocklands Road, North Sydney NSW 2060
Email: anzmtg0113@melanoma.org.au
Phone: +61 2 9911 7352

Documents (PDF downloads):


Return to Previous Page